Is Tarsus Pharmaceuticals, Inc. (TARS) a Buy, Sell, or Hold?
NASDAQ : TARS
Tarsus Pharmaceuticals, Inc. — Analyst Ratings
$61.32 USD
$2.28 (3.86%)
- Volume
- 797.14K
- Average Volume
- 976.11K
- Market Capitalization
- $2.64B
- P/E Ratio
- -53.79
- Dividend Yield
- 0.00%
- Price Target
- $89.00
- Year High
- $85.25
- Year Low
- $39.79
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.74
Analyst Consensus Summary
Consensus Rating
Strong Sell
10 Analysts
Rating Score
1/5
Recommendation Strength
Upside/Downside
-31.1%
vs Current Price
Price Target
$89.00
Average TargetPrice Target Range
Lowest Target
$68.00
-9.8% DOWNSIDE
Average Target
$89.00
Median Estimate
Highest Target
$98.00
-37.4% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 10
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 1 | 8 | 1 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| Guggenheim | Eddie Hickman | $89 | $56.25 | 2026-07-21 06:45 AM | 58.2% |
| Goldman Sachs | Andrea Tan | $51 | $67.245 | 2025-11-06 09:22 AM | -24.2% |
| Guggenheim | Eddie Hickman | $84 | $47.36 | 2025-05-02 07:51 AM | 77.4% |
| Barclays | Balaji Prasad | $62 | $48.78 | 2025-01-27 05:40 AM | 27.1% |